Correlation Between Mineralys Therapeutics, and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Kura Oncology, you can compare the effects of market volatilities on Mineralys Therapeutics, and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Kura Oncology.
Diversification Opportunities for Mineralys Therapeutics, and Kura Oncology
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Kura is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Kura Oncology go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Kura Oncology
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.64 times more return on investment than Kura Oncology. However, Mineralys Therapeutics, Common is 1.56 times less risky than Kura Oncology. It trades about -0.06 of its potential returns per unit of risk. Kura Oncology is currently generating about -0.21 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 29, 2024 and sell it today you would lose (137.00) from holding Mineralys Therapeutics, Common or give up 9.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Kura Oncology
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Kura Oncology |
Mineralys Therapeutics, and Kura Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Kura Oncology
The main advantage of trading using opposite Mineralys Therapeutics, and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
| Kura Oncology vs. Eliem Therapeutics | Kura Oncology vs. Scpharmaceuticals | Kura Oncology vs. Milestone Pharmaceuticals | Kura Oncology vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |